1. Home
  2. PEN vs TAP Comparison

PEN vs TAP Comparison

Compare PEN & TAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • TAP
  • Stock Information
  • Founded
  • PEN 2004
  • TAP 1873
  • Country
  • PEN United States
  • TAP United States
  • Employees
  • PEN N/A
  • TAP N/A
  • Industry
  • PEN Medical/Dental Instruments
  • TAP Beverages (Production/Distribution)
  • Sector
  • PEN Health Care
  • TAP Consumer Staples
  • Exchange
  • PEN Nasdaq
  • TAP Nasdaq
  • Market Cap
  • PEN 10.9B
  • TAP 11.2B
  • IPO Year
  • PEN 2015
  • TAP N/A
  • Fundamental
  • Price
  • PEN $266.93
  • TAP $53.59
  • Analyst Decision
  • PEN Strong Buy
  • TAP Hold
  • Analyst Count
  • PEN 16
  • TAP 13
  • Target Price
  • PEN $299.73
  • TAP $60.85
  • AVG Volume (30 Days)
  • PEN 554.0K
  • TAP 3.1M
  • Earning Date
  • PEN 07-29-2025
  • TAP 05-08-2025
  • Dividend Yield
  • PEN N/A
  • TAP 3.51%
  • EPS Growth
  • PEN N/A
  • TAP N/A
  • EPS
  • PEN 1.08
  • TAP 4.99
  • Revenue
  • PEN $1,240,100,000.00
  • TAP $11,334,700,000.00
  • Revenue This Year
  • PEN $14.60
  • TAP N/A
  • Revenue Next Year
  • PEN $14.17
  • TAP $0.80
  • P/E Ratio
  • PEN $247.65
  • TAP $10.73
  • Revenue Growth
  • PEN 13.17
  • TAP N/A
  • 52 Week Low
  • PEN $148.00
  • TAP $49.19
  • 52 Week High
  • PEN $310.00
  • TAP $64.66
  • Technical
  • Relative Strength Index (RSI)
  • PEN 39.77
  • TAP 35.99
  • Support Level
  • PEN $260.38
  • TAP $52.35
  • Resistance Level
  • PEN $275.41
  • TAP $57.57
  • Average True Range (ATR)
  • PEN 9.23
  • TAP 1.05
  • MACD
  • PEN -2.51
  • TAP -0.14
  • Stochastic Oscillator
  • PEN 15.55
  • TAP 23.75

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About TAP Molson Coors Beverage Company Class B

Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.

Share on Social Networks: